Global Information Lookup Global Information

Motexafin gadolinium information


Motexafin gadolinium
Clinical data
ATC code
  • none
Identifiers
CAS Number
  • 156436-89-4 checkY
PubChem CID
  • 158385
ChemSpider
  • 139341 checkY
UNII
  • 6433A42F4F
KEGG
  • D05080 checkY
ChEBI
  • CHEBI:50161 checkY
CompTox Dashboard (EPA)
  • DTXSID4037083 Edit this at Wikidata
Chemical and physical data
FormulaC52H72GdN5O14
Molar mass1148.42 g·mol−1
3D model (JSmol)
  • Interactive image
SMILES
  • CCC1=C(C2=CC3=NC(=CN=C4C=C(C(=CC4=NC=C5C(=C(C(=N5)C=C1[N-]2)CCCO)C)OCCOCCOCCOC)OCCOCCOCCOC)C(=C3CCCO)C)CC.CC(=O)[O-].CC(=O)[O-].[Gd+3]
InChI
  • InChI=1S/C48H66N5O10.2C2H4O2.Gd/c1-7-35-36(8-2)40-28-42-38(12-10-14-55)34(4)46(53-42)32-50-44-30-48(63-26-24-61-22-20-59-18-16-57-6)47(62-25-23-60-21-19-58-17-15-56-5)29-43(44)49-31-45-33(3)37(11-9-13-54)41(52-45)27-39(35)51-40;2*1-2(3)4;/h27-32,54-55H,7-26H2,1-6H3;2*1H3,(H,3,4);/q-1;;;+3/p-2/b39-27-,40-28-,41-27-,42-28-,45-31-,46-32-,49-31+,49-43+,50-32+,50-44+;;; checkY
  • Key:VAZLWPAHMORDGR-WRIGXHCHSA-L checkY
  (verify)

Motexafin gadolinium (proposed tradename Xcytrin) is an inhibitor of thioredoxin reductase and ribonucleotide reductase. It has been proposed as a possible chemotherapeutic agent in the treatment of brain metastases.[1]

  1. ^ Richards G, Mehta M (2007). "Motexafin gadolinium in the treatment of brain metastases". Expert Opinion on Pharmacotherapy. 8 (3): 351–9. doi:10.1517/14656566.8.3.351. PMID 17266469. S2CID 25542776.

and 9 Related for: Motexafin gadolinium information

Request time (Page generated in 0.7841 seconds.)

Motexafin gadolinium

Last Update:

Motexafin gadolinium (proposed tradename Xcytrin) is an inhibitor of thioredoxin reductase and ribonucleotide reductase. It has been proposed as a possible...

Word Count : 142

Ribonucleotide reductase inhibitor

Last Update:

deoxyribonucleotides (building blocks of DNA). Examples include: motexafin gadolinium. hydroxyurea fludarabine, cladribine, gemcitabine, tezacitabine,...

Word Count : 302

Ribonucleotide reductase

Last Update:

cancer, infections, and other diseases. The drugs hydroxyurea and Motexafin gadolinium interfere with the action of this enzyme. Elledge SJ, Zhou Z, Allen...

Word Count : 3493

Texaphyrin

Last Update:

the form of Motexafin gadolinium and Motexafin lutetium which are used as chemotherapeutics in the treatment of cancer. The two Motexafin compounds showed...

Word Count : 1508

Reactive oxygen species

Last Update:

cellular ROS stress level, either by direct ROS-generation (e.g. motexafin gadolinium, elesclomol) or by agents that abrogate the inherent antioxidant...

Word Count : 8480

Photodynamic therapy

Last Update:

radiosensitisers (Xcytrin) and chemosensitisers. Xcytrin, a gadolinium texaphyrin (motexafin gadolinium), has been evaluated in Phase III clinical trials against...

Word Count : 9498

Neutron capture therapy of cancer

Last Update:

Ford JM, Daniels MJ, Erhardt RJ, Frazer BH, et al. (January 2006). "Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei". Clinical...

Word Count : 9489

Thioredoxin reductase

Last Update:

types of cancer, including malignant mesothelioma. For example, motexafin gadolinium (MGd) is a new chemotherapeutic agent that selectively targets tumor...

Word Count : 2156

Index of oncology articles

Last Update:

monocyte – Montanide ISA-51 – Morinda citrifolia – morphology – motexafin gadolinium – moxifloxacin – MPNST – MRI – MRSI – MS 209 – MS-275 – mucinous...

Word Count : 5119

PDF Search Engine © AllGlobal.net